Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Using a wearable device to improve arm movement after stroke

Official title: Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

Run by Northwestern University · NCT03401762 · Data updated 2026-11-12

This study is testing a special device that helps stroke survivors improve their arm movement at home to see if it works better than a fake device.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment96 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJanuary 15, 2018
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedApril 8, 2026
Trial IDNCT03401762 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with hemiparesis from their first stroke, either chronic (at least 6 months post-stroke) or acute (within the past 21 days), who exhibit severe motor impairment.

Probably not a fit

Patients with cognitive or visual impairments that prevent them from following instructions or fully engaging with the MCI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the feasibility of a myoelectric-computer interface (MCI) designed to enhance arm movement in individuals who have experienced a stroke. It addresses the issue of impaired coordination caused by abnormal muscle co-activation, which affects recovery. Participants will use the MCI at home, and the study will compare its effects against a sham device in both chronic and acute stroke survivors. The study employs a randomized, controlled, and blinded design to ensure reliable results.

Why it matters

Potential benefit: If successful, this approach could significantly improve arm mobility and rehabilitation outcomes for stroke survivors.

How similar studies have gone: While the use of wearable devices in rehabilitation is an emerging field, this specific approach using MCI for muscle co-activation in stroke patients is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Chronic stroke participants

* Hemiparesis from first ever stroke at least 6 months prior to screening
* Severe motor impairment (FMA of 7-30)
* At least some voluntary shoulder and elbow muscle activation.

Acute stroke participants

* Hemiparesis from first ever stroke within the past 21 days
* Severe motor impairment (FMA of 3-20), or total Manual Motor Score of 1-8 combined in Shoulder Abduction and Finger Extensors

Exclusion Criteria:

* Cognitive impairment with at least moderately impaired attention, or unable to follow instructions of the MCI task
* Visual impairment (such as hemianopia) preventing full view of the screen
* Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest).
* Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study
* Inability to understand or follow commands in English due to aphasia or other reason
* Diffuse or multifocal infarcts
* Substantial arm pain preventing participation for 90 minutes a day
* New spasticity treatment (pharmacological or Botox)

Where it's running

  • Northwestern University
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.